HubSpot reports Q1 2026 results today with short sellers meaningfully more aggressive than they were six weeks ago, even as the stock bounced back over the past five sessions.
The short interest angle is worth watching. Bears have added roughly 37% more shares over the past month, pushing the short interest to 6.7% of the free float — a material jump from the ~4.7% level that prevailed through early April. The build has been concentrated in the last two weeks of April, when short shares climbed from under 2.6 million to around 3.6 million. Against that, the borrow market remains relaxed: cost to borrow has fallen sharply, now at just 0.25% annually, and availability is loose, meaning new shorts can enter without squeezing existing positions. The short score of 40.4 is moderate, sitting in the 38th percentile of peers. Options lean mildly defensive — the put/call ratio of 0.71 is above its 20-day average of 0.66 by about one standard deviation — but nothing like the extreme hedging seen in some software peers.
Price action adds a layer of ambiguity. The stock shed 4.4% on Wednesday to $235.16, giving back much of a 3.5% weekly gain. That one-day drop came amid broad software weakness — CRM, , and all fell between 3% and 5% on the day — so the move looks more like sector rotation than a HUBS-specific signal. Over the past month, the stock is down nearly 4%, and the gap between the current price and the analyst consensus target of roughly $345 is wide, implying around 46% upside to the Street's central view.
Analysts broadly stayed bullish but trimmed numbers ahead of today's print. Citigroup cut its target from $368 to $321 just last week while keeping a Buy, and UBS and Piper Sandler both reduced their targets in mid-April. Canaccord made the largest absolute cut, slashing from $485 to $350. Despite the target compression, no major firm has moved off a positive rating. The bull case rests on HubSpot's positioning as an AI democratiser for mid-market businesses, a strong cash position (net cash of nearly $2 billion), and an outcome-based pricing transition that proponents believe is still in early innings. Bears point to that same pricing shift as the risk: if the new model compresses near-term revenue recognition or fails to ramp inbound demand, the margin expansion story — already a work in progress — gets harder to tell.
Institutional ownership adds a note of conviction from the long side. T. Rowe Price added 731,927 shares in Q1, becoming the largest external holder at 10.9% of shares. Vanguard added 578,000 shares in the same period. These are not momentum trades. Insider activity, by contrast, has been one-directional: every recent trade on record is a sale, including an $1.9 million disposal from Executive Chairman Brian Halligan in late April and across-the-board sells from the CEO, CFO, and CTO on April 1. The net insider position over 90 days is a sale of approximately $9.1 million in value. Routine plan sales can explain some of this, but the pattern is worth noting against the institutional conviction on the other side.
Past prints offer a guidepost without a clean verdict. The February 2026 quarterly result triggered a 6.7% one-day decline, though the stock recovered to post a 7.3% gain over the following five sessions. The report today is less about whether HubSpot can grow and more about whether the outcome-based pricing transition is generating the pipeline momentum that justifies a consensus target sitting nearly 50% above the current share price.
See the live data behind this article on ORTEX.
Open HUBS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
